In addition, Mahmoud et al. [83] showed that hesperidin treatment could attenuate hyperglycemia-mediated oxidative stress and suppress the production of pro-inflammatory cytokines, such as TNF-α and IL-6, in HFD/STZ-induced type 2 diabetic rats. This evidence concerns the gene IL6 and type 2 diabetes mellitus.